{"url_path":"/sec/ango/8-k/2026-07-14/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/0001140361-26-028368-index.html","accession_number":"0001140361-26-028368","cik":"0001275187","ticker":"ANGO","issuer_name":"ANGIODYNAMICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1275187/0001140361-26-028368-index.html","primary_entity_key":"0001275187","primary_entity_name":"ANGIODYNAMICS INC"},"word_count":136,"has_tables":true,"body_markdown":"Item 2.02 – Results of Operations and Financial Condition.\n\nOn July 14, 2026, AngioDynamics, Inc. (“AngioDynamics”) issued a press release announcing financial results for the fiscal fourth quarter and full\nyear ended May 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1.\n\nThe information set forth in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the\nSecurities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, such information shall not be deemed to be incorporated by reference into any filing under the Securities Act\nof 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing."}